Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Sensory and Thermal Quantitative Testing in Children With Sickle Cell Disease.

Jacob E, Chan VW, Hodge C, Zeltzer L, Zurakowski D, Sethna NF.

J Pediatr Hematol Oncol. 2015 Apr;37(3):185-9. doi: 10.1097/MPH.0000000000000214.

PMID:
25014619
2.

Thermal pain and sensory processing in children with sickle cell disease.

O'Leary JD, Crawford MW, Odame I, Shorten GD, McGrath PA.

Clin J Pain. 2014 Mar;30(3):244-50. doi: 10.1097/AJP.0b013e318292a38e.

PMID:
23629596
3.

Patients with sickle cell disease have increased sensitivity to cold and heat.

Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA.

Am J Hematol. 2013 Jan;88(1):37-43. doi: 10.1002/ajh.23341. Epub 2012 Oct 31.

4.

Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease.

Brandow AM, Panepinto JA.

J Pediatr Hematol Oncol. 2016 May;38(4):288-93. doi: 10.1097/MPH.0000000000000532.

5.

Sickle cell disease in mice is associated with sensitization of sensory nerve fibers.

Kenyon N, Wang L, Spornick N, Khaibullina A, Almeida LE, Cheng Y, Wang J, Guptill V, Finkel JC, Quezado ZM.

Exp Biol Med (Maywood). 2015 Jan;240(1):87-98. doi: 10.1177/1535370214544275. Epub 2014 Jul 28.

6.

Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?

Ezenwa MO, Molokie RE, Wang ZJ, Yao Y, Suarez ML, Pullum C, Schlaeger JM, Fillingim RB, Wilkie DJ.

Pain Pract. 2016 Mar;16(3):282-93. doi: 10.1111/papr.12279. Epub 2015 Jan 12.

7.

Hand-arm vibration syndrome: clinical characteristics, conventional electrophysiology and quantitative sensory testing.

Rolke R, Rolke S, Vogt T, Birklein F, Geber C, Treede RD, Letzel S, Voelter-Mahlknecht S.

Clin Neurophysiol. 2013 Aug;124(8):1680-8. doi: 10.1016/j.clinph.2013.01.025. Epub 2013 Mar 16.

PMID:
23507585
8.

Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls.

Campbell CM, Carroll CP, Kiley K, Han D, Haywood C Jr, Lanzkron S, Swedberg L, Edwards RR, Page GG, Haythornthwaite JA.

Pain. 2016 Apr;157(4):949-56. doi: 10.1097/j.pain.0000000000000473.

9.

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes.

Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein F, Gierthmühlen J, Flor H, Geber C, Huge V, Krumova EK, Landwehrmeyer GB, Magerl W, Maihöfner C, Richter H, Rolke R, Scherens A, Schwarz A, Sommer C, Tronnier V, Uçeyler N, Valet M, Wasner G, Treede RD.

Pain. 2010 Sep;150(3):439-50. doi: 10.1016/j.pain.2010.05.002.

PMID:
20627413
10.

Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

Lang PM, Schober GM, Rolke R, Wagner S, Hilge R, Offenbächer M, Treede RD, Hoffmann U, Irnich D.

Pain. 2006 Sep;124(1-2):190-200. Epub 2006 May 22.

PMID:
16716518
11.

Sensory regeneration following intraoperatively verified trigeminal nerve injury.

Jääskeläinen SK, Teerijoki-Oksa T, Virtanen A, Tenovuo O, Forssell H.

Neurology. 2004 Jun 8;62(11):1951-7.

PMID:
15184595
12.

Neurophysiologic and quantitative sensory testing in the diagnosis of trigeminal neuropathy and neuropathic pain.

Jääskeläinen SK, Teerijoki-Oksa T, Forssell H.

Pain. 2005 Oct;117(3):349-57.

PMID:
16153774
13.

Persistent sensory dysfunction in pain-free herniotomy.

Aasvang EK, Kehlet H.

Acta Anaesthesiol Scand. 2010 Mar;54(3):291-8. doi: 10.1111/j.1399-6576.2009.02137.x. Epub 2009 Oct 15.

PMID:
19839945
14.

Sensory determinants of thermal pain.

Defrin R, Ohry A, Blumen N, Urca G.

Brain. 2002 Mar;125(Pt 3):501-10.

PMID:
11872608
15.

Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Khaleel M, Puliyel M, Shah P, Sunwoo J, Kato RM, Chalacheva P, Thuptimdang W, Detterich J, Wood JC, Tsao J, Zeltzer L, Sposto R, Khoo MCK, Coates TD.

Am J Hematol. 2017 Nov;92(11):1137-1145. doi: 10.1002/ajh.24858. Epub 2017 Aug 17.

PMID:
28707371
16.

An Evaluation of Central Sensitization in Patients With Sickle Cell Disease.

Campbell CM, Moscou-Jackson G, Carroll CP, Kiley K, Haywood C Jr, Lanzkron S, Hand M, Edwards RR, Haythornthwaite JA.

J Pain. 2016 May;17(5):617-27. doi: 10.1016/j.jpain.2016.01.475. Epub 2016 Feb 16.

17.

Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease.

Beverung LM, Varni JW, Panepinto JA.

J Pediatr Hematol Oncol. 2015 Mar;37(2):128-33. doi: 10.1097/MPH.0000000000000177.

18.
19.

A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale.

Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA.

J Pediatr Hematol Oncol. 2015 Apr;37(3):190-4. doi: 10.1097/MPH.0000000000000306.

PMID:
25575295
20.

Quantitative sensory testing of patients with long lasting Patellofemoral pain syndrome.

Jensen R, Hystad T, Kvale A, Baerheim A.

Eur J Pain. 2007 Aug;11(6):665-76. Epub 2007 Jan 3.

PMID:
17204440

Supplemental Content

Support Center